propensity of SM-3997 to displace 3H-ligands was tested in vitro in a number of receptor-binding assays. SM-3997 possessed a high affinity towards 5-HT1A receptors, low affinity towards dopamine (D2) and 5-HT2 receptors, and no affinity towards benzodiazepine (BZ), GABA, 5-HT1B and adrenergic receptors.
Abstract-The
propensity of SM-3997 to displace 3H-ligands was tested in vitro in a number of receptor-binding assays. SM-3997 possessed a high affinity towards 5-HT1A receptors, low affinity towards dopamine (D2) and 5-HT2 receptors, and no affinity towards benzodiazepine (BZ), GABA, 5-HT1B and adrenergic receptors.
Moreover, SM-3997 facilitated neither 3H-flunitrazepam binding nor 3H-muscimol binding . These results suggest that the action of SM-3997 may be mediated via central 5-HT1A receptors but not the BZ-GABA receptor complex. 413, 7(3, laxation and sedation, our results indicate that SM-3997 might lack these side effects which are often produced by BZ anxiolytics.
SM-3997 did not bind to adrenergic a,-, a2 or l3-receptors, and it showed low affinity towards D2 receptors (Table 1) . These would be consistent with the results in behavioral studies that SM-3997 had no effect on adrenergic nervous systems and had weak antidopamine action such as the inhibition of the climbing behavior induced by apomorphine in mice (1). However, since the dose of SM-3997 needed for the anti conflict action is much lower than that for antidopamine action (1), its effect on dopamine systems is not believed to be related to its anticonflict action. The most important finding of the present study is that SM-3997 has a selective action on 5-HT receptor subtypes (Fig. 1) . SM-3997 acted as a displacer of 3H-spiroperidol from 5-HT2 receptors in the cerebral cortex, but the potency was weak (K,=1.1±0.3 fM). SM-3997 displaced 3H-5-HT from 5-HT, receptors at concentrations from 10 nM to 10 ,eM. The Ki value for this effect was 0.77+0.12 jiM, but the displacement oc curred with a low Hill coefficient of 0.30+ 0.04. Pedigo et al. (3) have recently reported that 5-HT, receptors are heterogeneous. They defined 5-HT1A receptors as 3H-5-HT binding sites that are sensitive to nanomolar concentrations of spiroperidol, whereas 5 HT1 B receptors are insensitive to low con centrations of spiroperidol. The results ob tained in this study indicate that SM-3997 does not displace 3H-5-HT with a mono phasic inhibition curve. This suggests that SM-3997 may have different affinities with these 5-HT, receptor subtypes. Therefore, in order to estimate the affinity of SM-3997 towards 5-HT1B receptors, the binding study with 3H-5-HT in the presence of 1 ,uM spiroperidol, which blocks 3H-5-HT binding to 5-HT1A receptors without significantly affecting binding to 5-HT1B receptors, was performed. SM-3997 was ineffective on this subtype, the K; value being more than 10 aM. Secondly, we estimated the affinity of SM 3997 towards 5-HT, A receptors by the binding study with 0.5 nM 3H-8-hydroxy-2 (di-n-propylamino)tetralin (3H-8-OH-DPAT) which binds selectively to 5-HT1A receptors at low concentration (4). The K, value for SM-3997 against 5-HT, A receptors was found to be 25±1 nM with a Hill coefficient of 0.92+0.02.
Thus it appears that the low Hill coefficient for the displacement of 3H-5-HT binding by SM-3997 is due to the different affinities of SM-3997 towards these 5-HT, receptor subtypes.
In the present study, it was found that SM 3997 had a selective high-affinity towards 5-HT receptor subtypes, 5-HT,,, receptors. Our previous study indicates that SM-3997 induces the "serotonin behavioral syndrome" such as a flat body posture in rats (5). The specific binding sites for 3H-SM-3997 existed in rat brain, and their regional distribution was similar to that of 5-HT1A receptors (6). Moreover, 8-OH-DPAT, a 5-HT1A selective agonist shows anticonflict activity (7) and induces a flat body posture in rats (8). These evidence suggest that SM-3997 manifests anxiolytic action through 5-HT, A receptors. Further studies concerning the correlation between the effect of SM-3997 on 5-HT nervous systems and its anticonflict activity are in progress.
